An early intervention using biomarkers to predict acute myocardial infarction (AMI) will effectively reduce global heart attack incidence, particularly among high-risk patients with type 2 diabetes mellitus (T2DM). This study attempted to identify potential biomarkers by detecting changes in the levels of plasma proteins in T2DM patients following onset of AMI in comparison with those without AMI. Volunteer T2DM patients without AMI (control; n=10) and T2DM patients with AMI (n=10) were recruited. Plasma samples from these patients were evaluated via two-dimensional gel electrophoresis (2DE) to screen for proteins with level changes between the two P repair protein RAD50, serum albumin, apolipoprotein A-IV, caspase-6, aminoacyl tRNA synthase complex-interacting multifunctional protein 1, serotransferrin, retinol-binding protein 4, transthyretin, alpha-1-antitrypsin, apolipoprotein A-I and serum amyloid A. tetranectin and titin in plasma appeared to be closely associated with the onset of AMI among T2DM patients and can be used as potential biomarkers for prediction of a cardiac event, though this requires validation in a prospective cohort study.
Introduction
Acute myocardial infarction (AMI) was responsible for the deaths of at least seven million patients in 2012 [1] . According to a statistical analysis, type 2 diabetes mellitus (T2DM) is an vascular disease (CVD) (American Heart Association, 2017; http://www.heart.org/HEARTORG/Conditions/Diabetes/ were shown to have a two to four times higher risk of CVD risk group for AMI [2] million people globally, predominantly in developing coun tries, will have metabolic syndrome , which is linked with the cardiac condition.
Through proteomics, many researchers have been studying the use of biomarkers due to their ability to monitor suscep tibility to as well as progression and resolution of diseases, analysis [4] . Proteomics has been widely used as a means of iden known genome . Together with the availability of the entire a deeper understanding of both human genes and proteins.
translational modifications (PTMs) based on the isoelectric point, relative molecular mass, solubility, and relative abun dance of proteins [7] . These properties notwithstanding, 2DE allows for the isolation of proteins in microgram amounts for further structural analysis by mass spectrometry (MS) or pro ization of the human proteome . Because of its simplicity, used as biomarkers for human disease detection, including in various cancers, neurodegenerative diseases, and hepatic cir rhosis. Because human plasma contains an enormously com plasma has recently been further investigated and has shown potential for diagnosing Alzheimer's and atherosclerotic dis eases [10, 11] protein, creatine kinase, and cardiac troponin are already used as biomarkers in acute cardiac care [12] . Therefore, the human plasma proteome has the potential to predict the onset of AMI. Because acute AMI contributes to a large percentage of mortality worldwide, early intervention using biomarkers that help reduce the global heart attack incidence.
In this study, plasma samples were collected from T2DM volunteers with AMI three days after admission, and T2DM sub isoelectric points and relative molecular masses. Proteins with changes in abundance were subsequently identified using of this study was to use proteomic analysis to identify plasma proteins with altered abundance among T2DM patients follow ing the onset of AMI compared with patients without AMI.
Materials and methods

Recruitment of subjects
This study was conducted among diabetic Malaysian sub by the Ethical Committee (Institutional Review Board) of were collected from patients admitted to the UMMC Cardiol ogy and Coronary Care Wards, and control samples were col lected from patients attending the outpatients' clinic at UMMC Medical Clinic. Samples from admitted patients were col lected within three days following onset of AMI, depending on the patients' medical status. Each volunteer was interviewed and requested to complete a questionnaire concerning per sonal and health information, including smoking and alcohol Informed written consent was obtained from every patient prior to plasma collection. Blood samples were obtained by peripheral venous puncture and collected into plastic whole g was immediately divided into 100 μL aliquots and stored at smoking during the previous three months, antibiotic use dur in the study are shown in Table 1 .
Separation of proteins by two-dimensional gel electrophoresis DTT, 2% v/v v/v v/v v/v w/v Orange one Immobiline DryStrip Gel (pH 4-7 linear, 11 cm, GE Healthcare, Uppsala, Sweden) was passively rehydrated with hold). 
Analysis of gel images
ImageScanner III (GE Healthcare, Uppsala, Sweden). Image analysis was performed using Progenesis SameSpots (ver with the best resolution were chosen to represent each group and used for further analysis. In brief, the gel images were dance, the normalized volume was calculated for each pro tein spot that was detected by the software. The volumes for both groups were compared to determine the respective fold changes and P t calculated by the image analysis software. Each protein spot volume±standard error of the mean (SEM). The P [14] . This statistical analysis was performed with the help of a statistician, and P ent. The gel plugs were then reduced in 10 mmol/L DTT/100 ammonium bicarbonate for 20 min in the dark at room tem acetonitrile/100 mmol/L ammonium bicarbonate for 20 min with shaking, followed by dehydration with 100% acetonitrile at low speed at ambient temperature until the gel plugs were speed vacuum. The dried peptides were subsequently recon Micropipette Tips. According to the MASCOT search results, protein scores P led to the further selec tion of plasma tetranectin and titin for analysis by competitive ELISA. This immunoassay employed the quantitative sand wich enzyme immunoassay technique. Based on the manu facturer's instructions, protein determination was performed ten samples and the standard were pipetted into the appropri ate microtiter plate wells. In theory, any desired analyte pres ent in the samples was bound by the immobilized antibody.
benzidine substrate was added to the wells. Only those wells
The intensity of the developed color was proportional to the amount of analyte bound in the initial step. The color devel the addition of sulfuric acid solution, and the color intensity nm. The concentration of analyte in the samples was then determined by comparing the optical density of the samples to the standard curve generated for each antigen.
Results
Analysis of plasma proteins
Profiling of human plasma samples by 2DE separated hun dreds of protein spots based on different isoelectric points and relative molecular masses. A typical representative 2DE profile of plasma within the range of pH 4-7 with the rela tive molecular mass declining from 200 kDa to 10 kDa was performed on plasma samples from diabetic patients with AMI, the profiles obtained were similar to those of the con study were also generally comparable with those published tion and comparison, individual protein spots between the were obtained from the software and tabulated according to the respective protein labels. By using Progenesis SameSpots P etry analysis of the highly resolved spots was conducted in terms of the average normalized volumes, P P 10 were significantly upregulated and 24 were significantly downregulated in T2DM patients with AMI compared with altered abundance comprised a total of 17 plasma protein clusters.
Average normalised volumes of plasma protein spots of T2DM patients.
Protein
Average Amyloidosis, polyneuropathy, protein-energy malnutrition, carpal tunnel syndrome, hyperthyroxinaemia, neuropathy, autonomic neuropathy, atrial fibrillation, kidney disease, cancer, Alzheimer's disease, liver disease, heart disease, diarrhea, diabetes mellitus, decubitus ulcer, choroid plexus papilloma, cerebrovascular disease, hypothyroidism, myopathy, dementia, eye disease, hypervitaminosis A, hyperthyroidism, anorexia nervosa, carotenemia, thyrotoxicosis, anemia, brain disease, pneumonia, hypertension, Crohn's disease, cholestasis, short bowel syndrome, obesity, pancreatitis, phenylketonuria, blepharochalasis, and chronic obstructive pulmonary disease. Amyloidosis, familial Mediterranean fever, anemia, splenic artery aneurysm, rheumatoid arthritis, atherosclerosis, cancer, kidney disease, and coronary artery disease. Alpha-1-antitrypsin deficiency, chronic obstructive pulmonary disease, protein-losing enteropathy, liver disease, cancer, disease, rheumatoid arthritis, asthma, adult respiratory distress syndrome, hypersensitivity reaction type II disease, diarrhoea, kidney disease, interstitial lung disease, colitis, pneumothorax, hepatitis B, constrictive pericarditis, pneumonia, steatorrhoea, disseminated intravascular coagulation, congenital disorder of glycosylation, otitis media, diabetes mellitus, haemochromatosis, coronary artery Atherosclerosis, coronary artery disease, lipid metabolism disorder, diabetes mellitus, metabolic syndrome X, obesity, amyloidosis, hypertension, cerebrovascular disease, kidney disease, liver disease, cancer, heart disease, arthritis, polycystic ovary syndrome, hyperinsulinism, hyper homocysteinemia, arcus senilis, peripheral vascular disease, Alzheimer's disease, hyperlycaemia, dysbaric osteonecrosis, and hypothyroidism.
Transthyretin Alpha-1-antitrypsin Apolipoprotein A-I was performed on ten samples from each group, and these groups (with AMI) were calculated and found to be similar to the initial 2DE data. Ultimately, the concentrations of the two and 2DE approaches both demonstrated downregulation of AMI.
Discussion
Most of the identified proteins of altered abundance were linked with broad disease associations resulting from the response, cholesterol homeostasis, cardiac muscle tissue devel opment, and other pathophysiological responses (Universal Protein Resource, 2017; http://www.uniprot.org/). Some, including tetranectin and titin, were reportedly associated with cardiovascular disease and diabetes. Due to their asso ciations with cardiac metabolism pathways and presence in cardiac muscles, tetranectin and titin were further selected for concentration validation using ELISA. The results clearly showed regulation patterns similar to those found by the 2DE level for tetranectin was, however, much lower than that cal culated from the 2DE analysis. The different P values may be attributable to the presence of isoforms and/or PTMs of these proteins or the specificity of the antibodies used for ELISA. The significance level may be improved by increasing the number of samples and/or using antibodies that are highly that specifically binds to the plasminogen kringle 4 domain, thereby enhancing plasminogen activation [17] . It is primarily involved in tissue remodeling and development . Based on erty in thrombus breakdown. Hence, tetranectin dissolves the thrombus blocking the coronary artery and promotes better blood circulation to cardiac muscles. This implied role of tet studies of cardiac tetranectin in the formation and dissolution levels in patients suffering from stable CAD were decreased compared with those of healthy controls [21] . These studies are in agreement with the results obtained in this research. and the third most abundant muscle protein after myosin and actin. Also known as connectin, titin functions as a molecular spring and is responsible for the passive elasticity of muscle [22] .
diac and skeletal muscles. It is essential for the contraction of striated muscle tissues . Titin plays a crucial role in the temporal and spatial control of the assembly and elasticity of the highly ordered sarcomeres of the striated muscle [24] . Titin limits the range of motion of the sarcomere in tension, thus contributing to the passive stiffness of muscle. By provid ing connections at the level of individual microfilaments, titin contributes to the careful balance of forces between the halves of a sarcomere and ultimately maintains sarcomere integrity. Variations in the sequence of titin in different types of muscles, including cardiac and skeletal muscles, have been correlated with differences in the mechanical properties of these muscles. According to the UniProt database (Universal Protein Resource, 2017), titin is robustly linked with diverse cardiac processes, including blood coagulation, cardiac muscle hypertrophy, cardiac muscle tissue morphogenesis, cardiac myofibril assembly, detection of muscle stretch, and many others. kDa molecule. It is possible that the upregulation of titin in plasma is due to its dissociation from cardiac muscle when myocardial infarction is caused by prolonged ischemia. When tissue death occurs, the contraction of the striated cardiac mus cle tissue is altered. This pattern is in keeping with the clinical evaluation performed by Vassiliadis et al . In their study, first neoepitope biomarker that was specifically detected in serum and related to cardiac damage. In another serological fragment, in blood has been suggested to be a sensitive marker . Additionally, changes in titin phos phorylation and titin splicing occur in cardiac disease despite mutations in the titin gene [27] , demanding further study of this tion of more proteins can lead to insight into the usefulness of addition to cTn also improves sensitivity and rules out AMI. Thus, copeptin may help identify patients who may be safely discharged early from the emergency department . Apart from finding valuable diagnostic biomarkers, this proteomic study aimed to identify possible biomarkers prior to the onset of AMI. While the biological reasons for the linked tetranectin and titin have the potential to be used in early screening for heart disease. In the future, a longitudinal cohort study should be performed on similar patients at high risk for AMI to investigate whether tetranectin and titin can be used as biomarkers to predict cardiac arrest. The tetranectin level may indicate the status of cardiac thrombosis, whereas concentrations. The test kit will be suitable for use in diabetic clinics and hospitals if the proteins are found to be associated with T2DM groups with susceptibility to AMI.
In conclusion, tetranectin and titin in plasma may be useful risk T2DM patients.
